RNS Number : 2621X
Marwyn Acquisition Company II Ltd
30 April 2021
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

 

LEI: 2549008KZ7HM27V4O637

 

Marwyn Acquisition Company II Limited 

(the "Company")

Total Voting Rights

 

In accordance with the requirements of Disclosure and Transparency Rule 5.6.1, the Company is notifying the market that as at 30 April 2021 it has in issue 700,000 ordinary shares of no par value, with voting rights and 12 million A Shares1 with no voting rights. Accordingly, shareholders should use the total number of ordinary shares in the Company in issue of 700,000 as the denominator for the calculations by which they will determine whether they are required to notify their interest in the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority. 

 

Notes

1 The A Shares are ordinary shares with the same economic rights as the Company's ordinary shares but without voting rights. They are convertible into ordinary shares on a one-for-one basis at the time at which the Company next publishes a prospectus or equivalent document in relation to the further issue of ordinary shares.

 

Enquiries: 

 

Company Secretary

Antoinette Vanderpuije - 020 7004 2700

 

Finsbury - PR Adviser 

Rollo Head 07768 994 987 

Chris Sibbald 07855 955 531 

 

Investec Bank plc - Financial Adviser 020 7597 5970 

Christopher Baird 

Carlton Nelson 

Alex Wright 

 

WH Ireland Limited - Corporate Broker - +44 (0) 207 220 1666

Harry Ansell

Katy Mitchell

 

Further information on the Company can be found on its website at www.marwynac2.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website or any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAFLEDAFFEFA